Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

NCT04116320 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Unable to enroll enough patients to complete targeted enrollment in a reasonable time.

Conditions

Melanoma
Breast Cancer
Merkel Cell Carcinoma
Squamous Cell Cancer
Non Small Cell Lung Cancer
Cervical Cancer
Urothelial Carcinoma
Ovarian Cancer
Hepatocellular Carcinoma
Small-cell Lung Cancer
Microsatellite Instability High
Gastric Cancer
Esophageal Cancer

Interventions

DEVICE: Echopulse
DRUG: Poly ICLC
DRUG: Standard of Care PD-1 Therapy

Sponsor

Craig L Slingluff, Jr

Collaborators

[object Object]